Connected Car
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Age-related Macular Degeneration Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-related Macular Degeneration Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age-related Macular Degeneration Market Perspective (2017-2028)
2.2 Age-related Macular Degeneration Growth Trends by Region
2.2.1 Age-related Macular Degeneration Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Age-related Macular Degeneration Historic Market Size by Region (2017-2022)
2.2.3 Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028)
2.3 Age-related Macular Degeneration Market Dynamics
2.3.1 Age-related Macular Degeneration Industry Trends
2.3.2 Age-related Macular Degeneration Market Drivers
2.3.3 Age-related Macular Degeneration Market Challenges
2.3.4 Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-related Macular Degeneration Players by Revenue
3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2017-2022)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2017-2022)
3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
3.4 Global Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2021
3.5 Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2017-2022)
4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028)
5 Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2017-2022)
5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Age-related Macular Degeneration Market Size (2017-2028)
6.2 North America Age-related Macular Degeneration Market Size by Country (2017-2022)
6.3 North America Age-related Macular Degeneration Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size (2017-2028)
7.2 Europe Age-related Macular Degeneration Market Size by Country (2017-2022)
7.3 Europe Age-related Macular Degeneration Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2017-2028)
8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Country (2017-2022)
8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Age-related Macular Degeneration Market Size (2017-2028)
9.2 Latin America Age-related Macular Degeneration Market Size by Country (2017-2022)
9.3 Latin America Age-related Macular Degeneration Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2017-2028)
10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2017-2022)
10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Detail
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022)
11.1.5 Bayer HealthCare Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Age-related Macular Degeneration Introduction
11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Detail
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.4.5 Regeneron Pharmaceuticals Recent Development
11.5 Alcon
11.5.1 Alcon Company Detail
11.5.2 Alcon Business Overview
11.5.3 Alcon Age-related Macular Degeneration Introduction
11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2017-2022)
11.5.5 Alcon Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Age-related Macular Degeneration Introduction
11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2017-2022)
11.6.5 Allergan Recent Development
11.7 Avalanche
11.7.1 Avalanche Company Detail
11.7.2 Avalanche Business Overview
11.7.3 Avalanche Age-related Macular Degeneration Introduction
11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.7.5 Avalanche Recent Development
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Detail
11.8.2 Bausch+Lomb Business Overview
11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022)
11.8.5 Bausch+Lomb Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022)
11.9.5 Gilead Sciences Recent Development
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Detail
11.10.2 Iconic Therapeutics Business Overview
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022)
11.10.5 Iconic Therapeutics Recent Development
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Detail
11.11.2 Neurotech Pharmaceuticals Business Overview
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.11.5 Neurotech Pharmaceuticals Recent Development
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Detail
11.12.2 Ohr Pharmaceutical Business Overview
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022)
11.12.5 Ohr Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Age-related Macular Degeneration Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Age-related Macular Degeneration Market Share by Region (2017-2022)
Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Age-related Macular Degeneration Market Share by Region (2023-2028)
Table 10. Age-related Macular Degeneration Market Trends
Table 11. Age-related Macular Degeneration Market Drivers
Table 12. Age-related Macular Degeneration Market Challenges
Table 13. Age-related Macular Degeneration Market Restraints
Table 14. Global Age-related Macular Degeneration Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Age-related Macular Degeneration Market Share by Players (2017-2022)
Table 16. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2017-2022)
Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2023-2028)
Table 27. Global Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Age-related Macular Degeneration Revenue Market Share by Application (2017-2022)
Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Age-related Macular Degeneration Revenue Market Share by Application (2023-2028)
Table 31. North America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 41. Bayer HealthCare Company Detail
Table 42. Bayer HealthCare Business Overview
Table 43. Bayer HealthCare Age-related Macular Degeneration Product
Table 44. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 45. Bayer HealthCare Recent Development
Table 46. F. Hoffmann-La Roche Company Detail
Table 47. F. Hoffmann-La Roche Business Overview
Table 48. F. Hoffmann-La Roche Age-related Macular Degeneration Product
Table 49. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 50. F. Hoffmann-La Roche Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Age-related Macular Degeneration Product
Table 54. Novartis Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Regeneron Pharmaceuticals Company Detail
Table 57. Regeneron Pharmaceuticals Business Overview
Table 58. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
Table 59. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 60. Regeneron Pharmaceuticals Recent Development
Table 61. Alcon Company Detail
Table 62. Alcon Business Overview
Table 63. Alcon Age-related Macular Degeneration Product
Table 64. Alcon Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 65. Alcon Recent Development
Table 66. Allergan Company Detail
Table 67. Allergan Business Overview
Table 68. Allergan Age-related Macular Degeneration Product
Table 69. Allergan Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 70. Allergan Recent Development
Table 71. Avalanche Company Detail
Table 72. Avalanche Business Overview
Table 73. Avalanche Age-related Macular Degeneration Product
Table 74. Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 75. Avalanche Recent Development
Table 76. Bausch+Lomb Company Detail
Table 77. Bausch+Lomb Business Overview
Table 78. Bausch+Lomb Age-related Macular Degeneration Product
Table 79. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 80. Bausch+Lomb Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Age-related Macular Degeneration Product
Table 84. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Iconic Therapeutics Company Detail
Table 87. Iconic Therapeutics Business Overview
Table 88. Iconic Therapeutics Age-related Macular Degeneration Product
Table 89. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 90. Iconic Therapeutics Recent Development
Table 91. Neurotech Pharmaceuticals Company Detail
Table 92. Neurotech Pharmaceuticals Business Overview
Table 93. Neurotech Pharmaceuticals Age-related Macular DegenerationProduct
Table 94. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 95. Neurotech Pharmaceuticals Recent Development
Table 96. Ohr Pharmaceutical Company Detail
Table 97. Ohr Pharmaceutical Business Overview
Table 98. Ohr Pharmaceutical Age-related Macular DegenerationProduct
Table 99. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 100. Ohr Pharmaceutical Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2021 VS 2028
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-related Macular Degeneration Market Share by Application in 2021 & 2028
Figure 5. Drugstore Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Age-related Macular Degeneration Report Years Considered
Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Age-related Macular Degeneration Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Age-related Macular Degeneration Market Share by Region: 2021 VS 2028
Figure 12. Global Age-related Macular Degeneration Market Share by Players in 2021
Figure 13. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
Figure 15. North America Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Age-related Macular Degeneration Market Share by Country (2017-2028)
Figure 17. United States Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Age-related Macular Degeneration Market Share by Country (2017-2028)
Figure 21. Germany Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Age-related Macular Degeneration Market Share by Region (2017-2028)
Figure 29. China Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Age-related Macular Degeneration Market Share by Country (2017-2028)
Figure 37. Mexico Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Age-related Macular Degeneration Market Share by Country (2017-2028)
Figure 41. Turkey Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 44. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 45. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 46. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 47. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 48. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 49. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 50. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 51. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 52. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 53. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 54. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer HealthCare F. Hoffmann-La Roche Novartis Regeneron Pharmaceuticals Alcon Allergan Avalanche Bausch+Lomb Gilead Sciences Iconic Therapeutics Neurotech Pharmaceuticals Ohr Pharmaceutical